ICD-10-CM Billable Code

M05.619

Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid arthritis (RA) is a chronic autoimmune condition that primarily affects the joints, leading to inflammation, pain, and potential joint damage. When RA involves the shoulder joint along with other organs and body systems, it indicates a more systemic form of the disease. The ICD-10 code M05.619 specifically refers to rheumatoid arthritis of the shoulder with unspecified specifics but with involvement of other organs and systems. This condition can significantly impact daily activities and overall health if not properly managed.

Causes & Symptoms

Clinical Causes: Genetic predisposition: Certain genes increase the risk of developing RA. Environmental factors: Smoking and exposure to certain environmental toxins may trigger the disease. Immune system malfunction: The immune system mistakenly attacks synovial membranes in joints and other tissues. Hormonal influences: Hormonal changes may play a role, especially in women.

Key Symptoms: Joint pain and tenderness, especially in the shoulder, which may worsen over time. Swelling and warmth around the shoulder joint. Reduced shoulder mobility and stiffness, particularly in the morning or after periods of inactivity. Fatigue and generalized malaise. Signs of systemic involvement, which may include: Fever Weight loss Dry eyes or mouth due to secondary systemic effects. Involvement of other organs such as lungs, heart, or eyes, leading to additional symptoms like shortness of breath, chest pain, or visual disturbances.

Diagnostic & Treatment

Diagnosis Path: Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies to support RA diagnosis. Blood markers of inflammation such as elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Complete blood count to identify anemia or other blood abnormalities. Imaging studies like X-rays, ultrasound, or MRI to evaluate joint damage and inflammation. Additional tests like lung function tests or echocardiograms if systemic organ involvement is suspected.

Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs): such as methotrexate, which help slow disease progression. Biologic agents: targeted therapies like tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, or Janus kinase (JAK) inhibitors. Nonsteroidal anti-inflammatory drugs (NSAIDs): used to reduce pain and inflammation. Corticosteroids: for short-term control of inflammation, especially during flare-ups. Physical therapy: exercises and techniques to maintain joint function and reduce stiffness. Lifestyle modifications: including regular exercise, healthy diet, and smoking cessation. Monitoring and managing systemic involvement: collaborating with specialists such as cardiologists or pulmonologists for affected organs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.619 a billable ICD-10 code?
Yes, M05.619 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.619?
Clinical documentation must specify the nature of Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems and any associated comorbidities for accurate reporting.

Cite this Clinical Reference